Typed states for the displayed outbound observations.
Source: paper_references, paper_reference_links, observed 2026-08-05T05:49:19.775002Z
Paper Citation Record · LEDGER
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors
As of 15 August 2026, this Paper Citation Record lists 46 of 46 outbound references and 0 inbound Pith citation observations for arXiv:2509.04939.
A citation records a reference. It does not transfer a finding from one paper to another.
Coverage vector
One-hop event checks from named stored sources.
Source: scholarly_work_events, retraction_status_cache, observed 2026-08-14T06:32:32.682623+00:00
Pith citing papers itemized under the disclosed page cap.
Source: paper_references, paper_reference_links
A source-named dated measurement, never combined with another source.
Source: cited_works
Reference resolution
46 of 46 outbound references displayed
- verified exact37
- verified fuzzy2
- unresolved2
- parse uncertain0
- malformed identifier3
- metadata mismatch2
External citation measurements
No source-named external measurement is stored.
Outbound references
Observation 2d1f01e1-b7ad-45b1-8479-b0353d0626e6 · outbound
This paper cites Delivery technologies for cancer immunotherapy.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Delivery technologies for cancer immunotherapy
Reference 1
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.455166Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 298dc4a0-5ec2-4821-9d73-aaebddb15780 · outbound
This paper cites Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Reference 2
- Resolution
- unresolved
- no resolver link, observed 2026-08-05T05:49:19.538468Z
Source-reported events for the cited work
Unavailable: canonical work link unavailable.
Observation b398435c-4555-46e2-ad74-817fb94e8253 · outbound
This paper cites iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Reference 3
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.427235Z
Source-reported events for the cited work
correction dated 2019-04-30. Source: crossref record 10.1016/s1470-2045(19)30240-2->10.1016/s1470-2045(17)30074-8:correction, observed 2026-07-11T03:12:31.049135+00:00. This notice travels one citation hop only.
Observation 7ddadf5b-0157-4241-b803-7e0aab8a8b00 · outbound
This paper cites Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types
Reference 4
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.411151Z
Source-reported events for the cited work
correction dated 2025-03-03. Source: crossref record 10.1136/jitc-2024-010311corr1->10.1136/jitc-2024-010311:correction, observed 2026-07-11T03:07:12.739551+00:00. This notice travels one citation hop only.
Observation 43ab2120-b569-4f54-ac7d-ac3e1eaf8e91 · outbound
This paper cites Why PD -L1 expression varies between studies of lung cancer: results from a Bayesian meta -analysis.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Why PD -L1 expression varies between studies of lung cancer: results from a Bayesian meta -analysis
Reference 5
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.394913Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 3d5ea0ee-b24f-419e-806b-220503a42557 · outbound
This paper cites ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal –Anal Task Forces whitepaper.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal –Anal Task Forces whitepaper
Reference 6
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.378782Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 57b7cd80-c061-4047-9026-61e325d9996a · outbound
This paper cites Comprehensive human cell -type methylation atlas reveals origins of circulating cell -free DNA in health and disease.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Comprehensive human cell -type methylation atlas reveals origins of circulating cell -free DNA in health and disease
Reference 7
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.361809Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 99085dbd-aa6d-428e-9967-ac29bdfa2ba7 · outbound
This paper cites The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
Reference 8
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.344801Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 7fec7e57-bd33-4380-8186-5e84274e6a0b · outbound
This paper cites Cell -Free DNA and Apoptosis: How Dead Cells Inform About the Living.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Cell -Free DNA and Apoptosis: How Dead Cells Inform About the Living
Reference 9
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.326279Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 405ba787-3285-4df4-a799-d00f3d92d6cf · outbound
This paper cites The main sources of circulating cell -free DNA: Apoptosis, necrosis and active secretion.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors The main sources of circulating cell -free DNA: Apoptosis, necrosis and active secretion
Reference 10
- Resolution
- metadata mismatch
- raw_fallback, observed 2026-08-05T05:49:20.796278Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 96a69e91-a23c-4d82-b469-17e113bd6381 · outbound
This paper cites Double -stranded DNA in exosomes: a novel biomarker in cancer detection.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Double -stranded DNA in exosomes: a novel biomarker in cancer detection
Reference 11
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.310507Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 43db0ccf-9f51-4925-8dbf-516ddf89a5a9 · outbound
This paper cites Kinetics of circulating cell -free DNA for biomedical applications: critical appraisal of the literature.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Kinetics of circulating cell -free DNA for biomedical applications: critical appraisal of the literature
Reference 12
- Resolution
- malformed identifier
- doi_truncated, observed 2026-08-05T05:49:20.294256Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 810bd917-29e8-446c-8201-7b8d128bb2c1 · outbound
This paper cites Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities
Reference 13
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.277300Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 4fc7de63-3242-46b4-9c5d-9837be5bf5f2 · outbound
This paper cites Origins, structures, and functions of circulating DNA in oncology.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Origins, structures, and functions of circulating DNA in oncology
Reference 14
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.260967Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation a608f72f-e9db-40fa-9faa-4707182b4edf · outbound
This paper cites Current and Future Clinical Applications of ctDNA in Immuno -Oncology.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Current and Future Clinical Applications of ctDNA in Immuno -Oncology
Reference 15
- Resolution
- malformed identifier
- no resolver link, observed 2026-08-05T05:49:19.613440Z
Source-reported events for the cited work
Unavailable: canonical work link unavailable.
Observation 9787e6e3-3bfc-4c5b-9c70-286609e83d0e · outbound
This paper cites Non -random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Non -random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation
Reference 16
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.233844Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation f61a4903-ab85-456d-bafd-b8ebaf409ddb · outbound
This paper cites Enhanced detection of circulating tumor DNA by fragment size analysis.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Enhanced detection of circulating tumor DNA by fragment size analysis
Reference 17
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.217951Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 2ad8611f-f857-4c84-8c87-b46e281b7504 · outbound
This paper cites Cell-Free DNA Fragmentomics: The Novel Promising Biomarker.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Cell-Free DNA Fragmentomics: The Novel Promising Biomarker
Reference 18
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.201121Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 042078d5-c396-4ca6-9402-4a236f2fe688 · outbound
This paper cites BIABooster: Online DNA Concentration and Size Profiling with a Limit of Detection of 10 fg/μL and Application to High -Sensitivity Characterization of Circulating Cell -Free DNA.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors BIABooster: Online DNA Concentration and Size Profiling with a Limit of Detection of 10 fg/μL and Application to High -Sensitivity Characterization of Circulating Cell -Free DNA
Reference 19
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.184377Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 424bb5ba-c91d-4aaa-ae02-e424dc4e2fa8 · outbound
This paper cites Size and Concentration of Cell -Free DNA Measured Directly from Blood Plasma, without Prior DNA Extraction.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Size and Concentration of Cell -Free DNA Measured Directly from Blood Plasma, without Prior DNA Extraction
Reference 20
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.166246Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 6d59985a-efbb-406e-a4e1-2abe895dc0c6 · outbound
This paper cites Pretreatment neutrophil -to-lymphocyte ratio as a marker of outcomes in nivolumab -treated patients with advanced non -small-cell lung cancer.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Pretreatment neutrophil -to-lymphocyte ratio as a marker of outcomes in nivolumab -treated patients with advanced non -small-cell lung cancer
Reference 21
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.150706Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation da0d5039-df40-41cb-92c8-34af7c76d66e · outbound
This paper cites Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non –Small Cell Lung Cancer.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non –Small Cell Lung Cancer
Reference 22
- Resolution
- verified exact
- raw_fallback, observed 2026-08-05T05:49:20.707489Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 50a57073-5b69-4dac-a816-5ea09aabf093 · outbound
This paper cites Pembrolizumab plus Chemotherapy in Metastatic Non –Small-Cell Lung Cancer.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Pembrolizumab plus Chemotherapy in Metastatic Non –Small-Cell Lung Cancer
Reference 23
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.135790Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 0cd4bc2e-0d4d-4a2b-ae3c-13a7c9313357 · outbound
This paper cites an unresolved cited work.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Unresolved cited work
Reference 24
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.119404Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 06ad2ec5-99ac-4c14-94c1-85c25cacdb03 · outbound
This paper cites an unresolved cited work.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Unresolved cited work
Reference 25
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.103130Z
Source-reported events for the cited work
correction dated 2020-01-23. Source: crossref record 10.1016/s0140-6736(20)30116-1->10.1016/s0140-6736(19)32591-7:correction, observed 2026-07-11T03:17:24.633565+00:00. This notice travels one citation hop only.
correction dated 2020-02-21. Source: crossref record 10.1016/s0140-6736(20)30254-3->10.1016/s0140-6736(19)32591-7:correction, observed 2026-07-11T03:14:21.540322+00:00. This notice travels one citation hop only.
correction dated 2021-06-10. Source: crossref record 10.1016/s0140-6736(21)01119-3->10.1016/s0140-6736(19)32591-7:correction, observed 2026-07-11T03:17:39.319921+00:00. This notice travels one citation hop only.
Observation 1429c87c-c255-4b6d-b1d9-1b290a9cbd10 · outbound
This paper cites Pembrolizumab versus Chemotherapy for PD -L1–Positive Non –Small-Cell Lung Cancer.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Pembrolizumab versus Chemotherapy for PD -L1–Positive Non –Small-Cell Lung Cancer
Reference 26
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.086543Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation b668548a-eca3-42d8-9fce-8e486e7cce47 · outbound
This paper cites Comparison of Biomarker Modalities for Predicting Response to PD -1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta -analysis.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Comparison of Biomarker Modalities for Predicting Response to PD -1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta -analysis
Reference 27
- Resolution
- unresolved
- no resolver link, observed 2026-08-05T05:49:19.676948Z
Source-reported events for the cited work
Unavailable: canonical work link unavailable.
Observation d9dc194a-edad-4e50-b701-e2156a838660 · outbound
This paper cites Neutrophil-to-Lymphocyte ratio (NLR) and Platelet- to-Lymphocyte ratio (PLR) as prognostic markers in patients with non -small cell lung cancer 37 (NSCLC) treated with nivolumab.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Neutrophil-to-Lymphocyte ratio (NLR) and Platelet- to-Lymphocyte ratio (PLR) as prognostic markers in patients with non -small cell lung cancer 37 (NSCLC) treated with nivolumab
Reference 28
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.068620Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 0475d6a1-094b-4f77-831e-a989989e4a48 · outbound
This paper cites Neutrophil -to- Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Neutrophil -to- Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond
Reference 29
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.052297Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 032a792b-57db-4756-bd9a-239305222cb6 · outbound
This paper cites Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Reference 30
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.033532Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation e73af332-0d43-4deb-9311-47fbd092d472 · outbound
This paper cites A longitudinal circulating tumor DNA-based model associated with survival in metastatic non -small-cell lung cancer.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors A longitudinal circulating tumor DNA-based model associated with survival in metastatic non -small-cell lung cancer
Reference 31
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:20.015319Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation ffb75787-2454-41cf-9bdc-38f36d430a6a · outbound
This paper cites The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs
Reference 32
- Resolution
- malformed identifier
- doi_truncated, observed 2026-08-05T05:49:19.998737Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 098dd73f-7f04-42f1-9a08-f6fa36c68bfe · outbound
This paper cites Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Reference 33
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:19.982459Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation f05924b7-599e-4319-9ec0-a78eb942f7ef · outbound
This paper cites Cell -free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues -Of-Origin.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Cell -free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues -Of-Origin
Reference 34
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:19.966006Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation edab2a52-acb1-4bdf-825d-ee8d352a2702 · outbound
This paper cites Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus
Reference 35
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:19.948567Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 20956a65-0aa3-424d-b2c2-7a1f9628bab8 · outbound
This paper cites DNA Fragments in the Blood Plasma of Cancer Patients: Quantitations and Evidence for Their Origin from Apoptotic and Necrotic Cells1.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors DNA Fragments in the Blood Plasma of Cancer Patients: Quantitations and Evidence for Their Origin from Apoptotic and Necrotic Cells1
Reference 36
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-05T05:49:20.831643Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 4951f630-e9a4-444f-b1ed-ba012ae0eca8 · outbound
This paper cites Increased plasma DNA integrity in cancer patients.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Increased plasma DNA integrity in cancer patients
Reference 37
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-05T05:49:20.814248Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 44aed982-cc2f-4075-a69c-7161b9b9cfa7 · outbound
This paper cites A New Paradigm of the Origins of Circulating DNA in Patients with Cancer.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors A New Paradigm of the Origins of Circulating DNA in Patients with Cancer
Reference 38
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:19.930896Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 571ca28f-9c9b-4f1b-9786-20d16f1f3dba · outbound
This paper cites Like a Rolling Stone: Sting-Cgas Pathway and Cell -Free DNA as Biomarkers for Combinatorial Immunotherapy.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Like a Rolling Stone: Sting-Cgas Pathway and Cell -Free DNA as Biomarkers for Combinatorial Immunotherapy
Reference 39
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:19.915460Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 8955c197-eada-478b-bac0-5d53194aae26 · outbound
This paper cites Putative Origins of Cell -Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Putative Origins of Cell -Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms
Reference 40
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:19.897519Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation b117446b-6653-41e7-b044-6d231d6e9c69 · outbound
This paper cites Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies
Reference 41
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:19.880118Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 3761d2a5-c296-4d61-8c4a-1d107175591f · outbound
This paper cites The cytosolic DNA -sensing cGAS-STING pathway in cancer.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors The cytosolic DNA -sensing cGAS-STING pathway in cancer
Reference 42
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:19.864211Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation c19d24b5-82e5-42a9-ab4b-1ad2f15a72ed · outbound
This paper cites cGAS is activated by DNA in a length‐ dependent manner.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors cGAS is activated by DNA in a length‐ dependent manner
Reference 43
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:19.847526Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 40311d99-7fee-4e7f-ab5b-7a0d7c79a2f7 · outbound
This paper cites Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes
Reference 44
- Resolution
- metadata mismatch
- raw_fallback, observed 2026-08-05T05:49:20.543696Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation fc5dfc78-1f32-4d7f-8b7a-3a1bd223819e · outbound
This paper cites High Fragmentation Characterizes Tumour - Derived Circulating DNA.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors High Fragmentation Characterizes Tumour - Derived Circulating DNA
Reference 45
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:19.831167Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Observation 32160391-dd5a-4746-819c-1f18460c87fe · outbound
This paper cites Artificial Intelligence and Mechanistic Modeling for Clinical Decision Making in Oncology.
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors Artificial Intelligence and Mechanistic Modeling for Clinical Decision Making in Oncology
Reference 46
- Resolution
- verified exact
- doi, observed 2026-08-05T05:49:19.814726Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.
Pith citing papers
No inbound Pith citation observations are available.